Human Gastrointestinal Neoplasia‐Associated Myofibroblasts Can Develop from Bone Marrow‐Derived Cells Following Allogeneic Stem Cell Transplantation
Worthley, Daniel L., Ruszkiewicz, Andrew, Davies, Ruth, Moore, Sarah, Nivison‐Smith, Ian, Bik To, L., Browett, Peter, Western, Robyn, Durrant, Simon, So, Jason, Young, Graeme P., Mullighan, Charles G., Bardy, Peter G., Michael, Michael Z.
Published in Stem cells (Dayton, Ohio) (01.06.2009)
Published in Stem cells (Dayton, Ohio) (01.06.2009)
Get full text
Journal Article
Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange
Curley, Cameron, Pillai, Elango, Mudie, Kari, Western, Robyn, Hutchins, Cheryl, Durrant, Simon, Kennedy, Glen A.
Published in Transfusion (Philadelphia, Pa.) (01.02.2012)
Published in Transfusion (Philadelphia, Pa.) (01.02.2012)
Get full text
Journal Article
Efficacy of Soluble TNFα Inhibitor (Etanercept) for Treatment of Steroid Refractory Acute Graft Versus Host Disease (GVHD) Post Allogeneic Stem Cell Transplantation (SCT)
Kennedy, Glen A., Butler, Jason, Morton, James, Hill, Geoff R., Western, Robyn, Durrant, Simon
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Fludarabine/Melphalan Conditioning for Allogeneic Stem Cell Transplantation (SCT) in Elderly Patients with AML/MDS
Kennedy, Glen A., Butler, Jason, Durrant, Simon, Hill, Geoff R., Western, Robyn, Morton, James
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Allogeneic Transplant Outcomes in Imatinib-Refractory Chronic Myeloid Leukaemia (CML) Are Similar to Transplant Outcomes in Imatinib-Responsive/Imatinib-Naïve CML and Appear To Be Predicted by the EBMT Risk Score
Stylian, Steven, Fennelly, Eileen T., Butler, Jason P., Morton, James P., Western, Robyn, Hutchins, Cheryl J., Hill, Geoff R., Durrant, Simon T., Kennedy, Glen A.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Allogeneic Transplant Outcomes in Imatinib-Refractory Chronic Myeloid Leukaemia (CML) Are Similar to Transplant Outcomes in Imatinib-Responsive/Imatinib-Naïve CML and Appear To Be Predicted by the EBMT Risk Score
Stylian, Steven, Fennelly, Eileen T., Butler, Jason P., Morton, James P., Western, Robyn, Hutchins, Cheryl J., Hill, Geoff R., Durrant, Simon T., Kennedy, Glen A.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article